Hypofractionated Stereotactic Radiotherapy
Hypofractionated Stereotactic Radiotherapy is a radiation therapy with 7 clinical trials. Currently 3 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
0.0%
0 of 2 finished
100.0%
2 ended early
3
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas
A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT
Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence
Clinical Trials (7)
Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas
A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT
Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence
Perfexion Brain Metastasis
Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis
All 7 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 7